Pamir Ozan bought NAGE

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001834681-25-000005

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 14, 2025

Published

Nov 17, 2025

Ingested by INSIDER

Nov 5, 04:32 UTC

Last re-read

Nov 5, 04:32 UTC

Extracted facts

Filer

Pamir Ozan

Role

Chief Financial Officer

Transaction

Open-market purchaseAs filed: “P”

Asset

Niagen Bioscience, Inc.

Ticker

NAGE

Shares

2,220.44

Price per share

$6.85

Value

$15,210

Execution date (reported)

Nov 14, 2025

Owned after transaction

2,220 shares

Days from execution to publication

3

Calculation

What this establishes

Pamir Ozan filed this Form 4 reporting a open-market purchase of NAGE on Nov 14, 2025. It became public on Nov 17, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Financial Officer

Pamir Ozancik:0001834681

Issuer

Niagen Bioscience, Inc.cik:0001386570

Revision history · 0

No field has changed since this record was first ingested.